IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Good morning, everyone. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at Morgan Stanley. Before we begin, for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your Morgan Stanley sales rep.
So it's my great pleasure this morning to have CEO and Chairman of IQVIA, Ari Bousbib; and Head of Investor Relations, Nick Childs, on stage here with me. Now for those of you who've been following the space for a while, Ari is a bit of a rare commodity at sell-side sort of conferences. In my many years at JPMorgan, he's also one of those health care CEOs that's allergic to the Westin St. Francis. So it is truly a privilege to share the stage with you.
Questions & Answers
Maybe to kick things off, Ari, can you just outline for us what you view as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |